Ohcanbohtosat - Chng, Wee-Joo
- Čájehuvvo 1 - 20 / 140
- Sirdás čuovvovaš siidui
-
1
MicroRNA: Important Player in the Pathobiology of Multiple Myeloma Dahkki Bi, Chonglei, Chng, Wee Joo
Almmustuhtton 2014Teaksta -
2
MMSET: Role and Therapeutic Opportunities in Multiple Myeloma Dahkki Xie, Zhigang, Chng, Wee Joo
Almmustuhtton 2014Teaksta -
3
-
4
-
5
-
6
-
7
-
8
-
9
Recent advances in acute promyelocytic leukaemia Dahkki Ng, Chin-Hin, Chng, Wee-Joo
Almmustuhtton 2017Teaksta -
10
CAR T-cell therapy in multiple myeloma: more room for improvement Dahkki Teoh, Phaik Ju, Chng, Wee Joo
Almmustuhtton 2021Teaksta -
11
Molecular switch of EZH2 in hypoxia Dahkki Mahara, Sylvia, Chng, Wee Joo, Yu, Qiang
Almmustuhtton 2016Teaksta -
12
-
13
-
14
-
15
-
16
The emerging roles of exosomes in leukemogeneis Dahkki Zhou, Jianbiao, Wang, Sam, Sun, Kangyun, Chng, Wee-Joo
Almmustuhtton 2016Teaksta -
17
STAT3: A Promising Therapeutic Target in Multiple Myeloma Dahkki Chong, Phyllis S. Y., Chng, Wee-Joo, de Mel, Sanjay
Almmustuhtton 2019Teaksta -
18
Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers Dahkki Li, Boheng, Wan, Qin, Li, Zhubo, Chng, Wee-Joo
Almmustuhtton 2021Teaksta -
19
Metabolic Vulnerabilities in Multiple Myeloma Dahkki Lim, Julia S. L., Chong, Phyllis S. Y., Chng, Wee-Joo
Almmustuhtton 2022Teaksta -
20